I

InDex Pharmaceuticals Holding AB
STO:FLERIE

Watchlist Manager
InDex Pharmaceuticals Holding AB
STO:FLERIE
Watchlist
Price: 45.3 SEK 1.59% Market Closed
Market Cap: 3.5B SEK
Have any thoughts about
InDex Pharmaceuticals Holding AB?
Write Note

Relative Value

The Relative Value of one FLERIE stock under the Base Case scenario is 0.002 SEK. Compared to the current market price of 45.3 SEK, InDex Pharmaceuticals Holding AB is Overvalued by 100%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

FLERIE Relative Value
Base Case
0.002 SEK
Overvaluation 100%
Relative Value
Price
I
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
47
vs Industry
7
Median 3Y
1.3
Median 5Y
34 349.2
Industry
2.5
vs History
vs Industry
Median 3Y
-244
Median 5Y
-598
Industry
21.9
Forward
-91.5
vs History
vs Industry
Median 3Y
-227.1
Median 5Y
-542.9
Industry
16.5
vs History
vs Industry
Median 3Y
-225.7
Median 5Y
-537.2
Industry
23.6
vs History
85
vs Industry
4
Median 3Y
73.9
Median 5Y
157
Industry
2.1
vs History
47
vs Industry
7
Median 3Y
-1.7
Median 5Y
25 534.2
Industry
2.6
vs History
vs Industry
Median 3Y
-326.5
Median 5Y
-2 310.4
Industry
5.2
vs History
vs Industry
Median 3Y
-236.2
Median 5Y
-603.1
Industry
13.3
Forward
-10.3
vs History
vs Industry
Median 3Y
-233.8
Median 5Y
-597.1
Industry
16.6
Forward
-10.3
vs History
vs Industry
Median 3Y
-224.8
Median 5Y
-541.7
Industry
15.6
vs History
vs Industry
Median 3Y
-224.8
Median 5Y
-541.7
Industry
19.1
vs History
55
vs Industry
Median 3Y
0.8
Median 5Y
4
Industry
1.9

Multiples Across Competitors

FLERIE Competitors Multiples
InDex Pharmaceuticals Holding AB Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
SE
InDex Pharmaceuticals Holding AB
STO:FLERIE
3.5B SEK 35 364.1 -13.1 -12.9 -12.9
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
710.5B USD 17.4 84.9 45.7 51
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
DK
Novo Nordisk A/S
CSE:NOVO B
3.3T DKK 12.3 35 24.3 27.8
US
Johnson & Johnson
NYSE:JNJ
373.5B USD 4.3 25.4 12.3 16
US
Merck & Co Inc
NYSE:MRK
251.1B USD 4 20.7 10.5 12.5
CH
Roche Holding AG
SIX:ROG
202.7B CHF 3.5 17.6 9.9 11.8
CH
Novartis AG
SIX:NOVN
183.3B CHF 4.1 11.6 10.1 14
UK
AstraZeneca PLC
LSE:AZN
162.4B GBP 4.1 31.6 169.4 253.9
IE
Endo International PLC
LSE:0Y5F
146B USD 63 -49.9 234.4 587.7
P/E Multiple
Earnings Growth
SE
I
InDex Pharmaceuticals Holding AB
STO:FLERIE
Average P/E: 32.4
Negative Multiple: -13.1
N/A
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A
US
Eli Lilly and Co
NYSE:LLY
84.9
451%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A
DK
Novo Nordisk A/S
CSE:NOVO B
35
86%
US
Johnson & Johnson
NYSE:JNJ
25.4
-22%
US
Merck & Co Inc
NYSE:MRK
20.7
7 321%
CH
Roche Holding AG
SIX:ROG
17.6
32%
CH
Novartis AG
SIX:NOVN
11.6
21%
UK
AstraZeneca PLC
LSE:AZN
31.6
177%
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -49.9 N/A

See Also

Discover More
Back to Top